4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000024
Chief Financial Officer gave up 1,056 shares (to pay taxes)
- Chief Financial Officer acquired 3,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hirsch Andrew · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-22 | Exercise or conversion : show line 1 in the form | +3,333 | 17,574 | D | ||
| 2020-02-24 | Shares withheld for taxes : show line 2 in the form | −1,056 | $48.66 | $51,385 | 16,518 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-22 | Exercise or conversion : show line 3 in the form Restricted stock units | −3,333 | 6,667 | D |
Loading xslF345X03/wf-form4_158266604156652.xml…